References & Sources

Official adult immunization schedule for Indonesia. Primary source for condition-based recommendations including Herpes Zoster, RSV, Influenza, and Pneumococcal as priority vaccines for adults with chronic conditions.

Pocket reference guide for adult vaccination in Indonesia. Provides clinical context, dosing schedules, and contraindications for all recommended adult vaccines including newly approved RSV and recombinant Herpes Zoster vaccines.

Adult vaccination card identifying the four vaccines prioritized for adults with comorbidities: Herpes Zoster (Recombinant), RSV, Influenza, and Pneumococcal. Basis for the "Vaccines to Prioritise Now" section in CareMate's output.

Annual age- and condition-based vaccination schedule covering all recommended vaccines for adults 19 years and older. Used for routine scheduling logic and catch-up recommendations.

Guidelines recommending recombinant zoster vaccine for adults ≥50 and immunocompromised adults ≥19. Informed the age-based and condition-based zoster recommendation thresholds in CareMate.

First ACIP recommendations for RSV vaccines in adults ≥60 and high-risk younger adults. Used to define RSV eligibility criteria in CareMate's recommendation engine.

Global recommendations for influenza vaccine use in adults, including priority groups and annual revaccination rationale. Basis for influenza as a universal annual priority in CareMate.

Global guidance on zoster vaccine use, safety in immunocompromised patients, and priority populations. Supports PAPDI's condition-based recommendations in CareMate.

Guidance for PCV use in older adults and high-risk groups. Used to define pneumococcal eligibility for adults with diabetes, lung disease, heart disease, and immunocompromising conditions.

First WHO global guidance on RSV vaccines for adults, providing evidence base for RSV as a priority vaccine in adults with underlying conditions.

Indonesian national immunization program guidelines for adults, including locally relevant vaccines and schedules adapted to Indonesia's epidemiological context.

Indonesian Food and Drug Authority authorizations for COVID-19, RSV, and Herpes Zoster vaccines in Indonesia. Ensures all vaccines recommended by CareMate are locally approved.